# Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas

> **NCT03677024** · NA · WITHDRAWN · sponsor: **Fudan University**

## Conditions studied

- Endometrial Endometrioid Adenocarcinoma

## Interventions

- **PROCEDURE:** SLN arm

## Key facts

- **NCT ID:** NCT03677024
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02-06
- **Primary completion:** 2021-10-07
- **Final completion:** 2021-10-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was not approved by the Ethics Committee
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03677024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03677024, "Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03677024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*